Alcon AG (NYSE:ALC)
85.04 USD
+0.280 0.330%Sponsored Reports
Previous Close (in USD) | 84.76 |
---|---|
Change | +0.280 0.330% |
52 W H/L (in USD) | 101.100/73.250 |
EBITDA (in USD) | 2357M |
PE Ratio | 36.95 |
Volume | 54315 |
Diluted Eps TTM | 2.34 |
Total Assets (in USD) | 29614M |
---|---|
Total Liabilities (in USD) | 8990M |
Revenue TTM (in USD) | 9761M |
Cash (in USD) | 1094M |
Market Cap (in USD) | 42,949.390 M |
Revenue Per Share TTM | 19.757 |
Gross Profit TTM (in USD) | 4807M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Dividend Paid
Alcon AG
Employees: 25000
Key Executives
Sr. No. | Name | Title | Year Born |
---|---|---|---|
1. | Mr. F. Michael Ball | Exec. Chairman | 1955 |
2. | Mr. David J. Endicott | CEO & Director | 1965 |
3. | Mr. Arthur B. Cummings M.D. | Exec. Director | 1962 |
4. | Mr. Timothy C. Stonesifer | Chief Financial Officer | 1967 |
5. | Margaret Buckley | Chief Accounting Officer | NA |
6. | Dr. Franck Leveiller | Sr. VP, Head of Global R&D and Chief Scientific Officer | NA |
7. | Ms. Sue-Jean Lin | Sr. VP & Chief Information and Transformation Officer | 1969 |
8. | Mr. Royce R. Bedward | Sr. VP, Gen. Counsel & Corp. Sec. | 1966 |
9. | Mr. Laurent Attias | Head of Corp. Devel., Strategy, BD&L and M&A | 1968 |
10. | Ms. Kimberly Martin | Sr. VP & Chief HR Officer | 1975 |
Peers
Sector: Healthcare
Industry: Medical Instruments & Supplies
Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
ISRG
Intuitive Surgical Inc |
-2.790 0.532% | 524.88 | 73.050 | 61.728 | 19.145 | 10.247 | 18.408 | 59.920 |
ESLOY
Essilor International SA |
+0.460 0.383% | 120.61 | 35.390 | 24.814 | 3.630 | 2.204 | 3.996 | 16.255 |
ESLOF
EssilorLuxottica Société anonyme |
0.000 0.000% | 237.25 | 35.710 | 25.126 | 3.623 | 2.229 | 3.995 | 16.251 |
BDX
Becton Dickinson and Company |
-0.430 0.189% | 226.34 | 37.720 | 15.924 | 3.252 | 2.490 | 4.085 | 17.104 |
Income Statement
(Currency in USD)Breakdown | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
---|---|---|---|---|---|
Income Before Tax | 832M | 463M | 418M | -635M | -332M |
Minority Interest | - | - | - | - | - |
Net Income | 974M | 335M | 376M | -531M | -656M |
Selling General Administrative | 3209M | 3068M | 3057M | 2694M | 2847M |
Gross Profit | 5247M | 4748M | 4652M | 2940M | 3662M |
Reconciled Depreciation | 1221M | 1123M | 1219M | 1626M | 1425M |
Ebit | 1021M | 616.586M | 539.145M | -611.367M | -199M |
Ebitda | 2242M | 1776.429M | 1760.738M | 1112M | 1226M |
Depreciation And Amortization | 1221M | 1159.843M | 1221.593M | 1723.367M | 1425M |
Operating Income | 1039M | 672M | 580M | -482M | -187M |
Other Operating Expenses | 8416M | 8045M | 7711M | 7315M | 7695M |
Interest Expense | 189M | 134M | 120M | 124M | 113M |
Tax Provision | -142M | 128M | 42M | -104M | 324M |
Interest Income | 45M | 16M | 146M | 6M | 8M |
Net Interest Income | -155M | -146M | -162M | -131M | -125M |
Income Tax Expense | -142M | 128M | 42M | -104M | 324M |
Total Revenue | 9455M | 8717M | 8291M | 6833M | 7508M |
Total Operating Expenses | 4208M | 4076M | 4072M | 3422M | 3849M |
Cost Of Revenue | 4208M | 3969M | 3639M | 3893M | 3846M |
Total Other Income Expense Net | -207M | -209M | -162M | -153M | -20M |
Net Income From Continuing Ops | 974M | 335M | 376M | -531M | -656M |
Net Income Applicable To Common Shares | - | 335M | 376M | -531M | -656M |
Balance Sheet
(Currency in USD)Breakdown | 31-12-2023 | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 |
---|---|---|---|---|---|
Total Assets | 29614M | 29209M | 27999M | 27600M | 27655M |
Intangible Assets | 9060M | 9689M | 8765M | 9097M | 10231M |
Other Current Assets | 241.956M | 418M | 95M | 404M | 90M |
Total Liab | 8990M | 9532M | 8743M | 8778M | 8352M |
Total Stockholder Equity | 20617.016M | 19677M | 19256M | 18822M | 19303M |
Other Current Liab | 1338.199M | 1664M | 1287M | 1040M | 1064M |
Common Stock | 19.993M | 20M | 20M | 20M | 20M |
Capital Stock | 20M | 20M | 20M | 20M | 20M |
Retained Earnings | - | - | 19356M | 18899M | 19355M |
Good Will | 8926M | 8970M | 8905M | 8905M | 8905M |
Other Assets | -10.028M | 833M | 1365M | 1515M | 1512M |
Cash | 1094M | 980M | 1575M | 1557M | 822M |
Cash And Equivalents | - | - | - | - | - |
Total Current Liabilities | 2479.16M | 2782M | 2472M | 2258M | 2300M |
Current Deferred Revenue | -0.84M | 89M | 108M | 110M | 97M |
Net Debt | 4041M | 4088M | 2904M | 2939M | 2982M |
Short Term Debt | 216M | 168M | 174M | 232M | 306M |
Short Long Term Debt | 135M | 97M | 107M | 162M | 245M |
Short Long Term Debt Total | 5135M | 5068M | 4479M | 4496M | 3804M |
Other Stockholder Equity | - | 19657M | 19236M | 18802M | -19355M |
Property Plant Equipment | - | 4416M | 4083M | 3783M | 3437M |
Total Current Assets | 5647M | 5193M | 5386M | 4987M | 4236M |
Long Term Investments | 319M | 108M | 52M | 40M | 59M |
Short Term Investments | 7M | -179M | 3M | 12M | 33M |
Net Receivables | 1981.329M | 1686M | 1814M | 1382M | 1786M |
Long Term Debt | 4594M | 4541M | 3966M | 3949M | 3218M |
Inventory | 2322M | 2109M | 1899M | 1644M | 1505M |
Accounts Payable | 811M | 861M | 903M | 876M | 833M |
Accumulated Other Comprehensive Income | 20597.023M | 19657M | 19236M | 18802M | 19283M |
Non Currrent Assets Other | 496.15M | 243M | 399M | 211M | 433M |
Non Current Assets Total | 23967M | 24016M | 22613M | 22613M | 23419M |
Capital Lease Obligations | 406M | 430M | 406M | 385M | 341M |
Long Term Debt Total | - | - | 4305M | 4264M | 3498M |
Cash Flow
(Currency in USD)Breakdown | 31-12-2022 | 31-12-2021 | 31-12-2020 | 31-12-2019 | 31-12-2018 |
---|---|---|---|---|---|
Investments | -1865M | -18M | -572M | -1011M | -1001M |
Total Cashflows From Investing Activities | -1865M | -1198M | -572M | -1011M | -1001M |
Total Cash From Financing Activities | -8M | -123M | 466M | 659M | -78M |
Net Income | 335M | 376M | -531M | -656M | -227M |
Change In Cash | -595M | 18M | 735M | 595M | 55M |
Begin Period Cash Flow | 1575M | 1557M | 822M | 227M | 172M |
End Period Cash Flow | 980M | 1575M | 1557M | 822M | 227M |
Total Cash From Operating Activities | 1217M | 1345M | 823M | 920M | 1140M |
Depreciation | 1123M | 1219M | 1626M | 1425M | 1638M |
Other Cashflows From Investing Activities | - | -18M | -5M | -1M | -1M |
Dividends Paid | -100M | -54M | 54M | 54M | 54M |
Change To Inventory | -217M | -326M | -159M | -108M | -150M |
Sale Purchase Of Stock | - | - | - | - | - |
Other Cashflows From Financing Activities | 2428M | 3M | 535M | 2720M | -78M |
Capital Expenditures | 745M | 1180M | 567M | 676M | 712M |
Change In Working Capital | -527M | -314M | -45M | -48M | 80M |
Other Non Cash Items | 18M | -116M | -228M | -208M | -44M |
Free Cash Flow | 472M | 165M | 256M | 244M | 428M |
Funds
Sr. No. | Name | Purchased On | Shares |
---|---|---|---|
1. | Vanguard Total Intl Stock Index Inv | 1 month ago | 6882177 |
2. | Impax Global Opportunities Strategy Comp | 2 months ago | 5202550 |
3. | UBS: Global Equity | 5 months ago | 4901833 |
4. | Vanguard Developed Markets Index Admiral | 1 month ago | 4247749 |
5. | Vanguard Instl Ttl Intl Stk Mkt Idx TrII | 1 month ago | 3441804 |
6. | iShares Core MSCI EAFE ETF | 3 weeks ago | 3131390 |
7. | T. Rowe Price US Mid-Cap Growth Equity | 2 months ago | 3092400 |
8. | T. Rowe Price Mid-Cap Growth | 1 month ago | 3089400 |
9. | UBS(CH)IF Equities CH All NSL I-B-acc | 3 weeks ago | 2977133 |
10. | Vanguard Windsor™ II Inv | 2 months ago | 2918000 |
11. | Comgest Growth Europe EUR Acc | 3 weeks ago | 2812028 |
12. | Harding Loevner International Eq Instl | 2 months ago | 2686418 |
13. | SWC (CH) IEF Switzerland Ttl Resp GT CHF | 1 month ago | 2315153 |
14. | Fidelity Series Overseas | 1 month ago | 2252350 |
15. | EAFE Equity Index Fund F | 2 months ago | 2119193 |
16. | Allspring Special Mid Cap Value Inst | 1 month ago | 2055850 |
17. | Allspring Special US Mid Cap Value Eq | 2 months ago | 2055850 |
18. | BlackRock Mid-Cap Growth Equity Instl | 1 month ago | 1936763 |
19. | ClearBridge Large Cap Growth A | 2 months ago | 1904963 |
20. | UBS (CH) IF - Eq CH All ESG NSL I-A-acc | 3 weeks ago | 1875116 |
Institutions
Sr. No. | Name | Purchased On | Shares |
---|---|---|---|
1. | Harding Loevner L.P. | 2 months ago | 9270977 |
2. | Zurcher Kantonalbank | 2 months ago | 8624165 |
3. | Bank of New York Mellon Corp | 2 months ago | 7802818 |
4. | Vontobel Holding Ltd. | 2 months ago | 7368048 |
5. | ClearBridge Advisors, LLC | 2 months ago | 7260378 |
6. | Aristotle Capital Management LLC | 2 months ago | 11867282 |
7. | T. Rowe Price Investment Management,Inc. | 2 months ago | 6390313 |
8. | Ako Capital Llp | 2 months ago | 6157815 |
9. | UBS Group AG | 2 months ago | 5586730 |
10. | Select Equity Group LP | 2 months ago | 5384201 |
11. | Legal & General Group PLC | 2 months ago | 5251058 |
12. | Amundi | 2 months ago | 4885179 |
13. | Bank of America Corp | 2 months ago | 4215947 |
14. | Brown Brothers Harriman & Co | 2 months ago | 4022125 |
15. | Mackenzie Investments | 2 months ago | 3915076 |
16. | Sustainable Growth Advisers, LP | 2 months ago | 3908079 |
17. | Vanguard Group Inc | 2 months ago | 19365374 |
18. | FMR Inc | 2 months ago | 14370140 |
19. | NORGES BANK | 5 months ago | 12346501 |
20. | UBS Asset Mgmt Americas Inc | 2 months ago | 12049888 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).